Medicenna Therapeutics Corp. (TSX: MDNA)

Medicenna Therapeutics Income Statement

Financials in millions CAD. Fiscal year is April - March.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Cost of Revenue	0.01	0.04	0.04	0.01	0.01	0	0	0	0	0
Gross Profit	-0.01	-0.04	-0.04	-0.01	-0.01	0	0	0	0	0
Selling, General & Admin	6.99	7.72	6.49	2.49	2.21	3	4.02	0.47	0	0
Research & Development	9.3	14.72	10.87	5.87	3.02	5.09	4.23	0.77	0	0
Other Operating Expenses	0.01	0.04	0.04	-0.12	-0.5	-0.66	-0.55	-0.04	0	0
Operating Expenses	16.3	22.47	17.4	8.24	4.73	7.42	7.7	1.2	0	0
Operating Income	-21.64	-22.3	-17.19	-8.21	-4.73	-7.42	-7.7	-1.2	-0	-0
Interest Income	0.91	0.07	0.31	0.01	0	0	0.03	0	0	0
Interest Expense	-11.6	0.07	0	0	0	0	0	0	0	0
Other Expense / Income	0.91	0.28	0.42	0.08	-0.04	-	-0.03	0.13	0	0
Pretax Income	-10.05	-22.58	-17.29	-8.28	-4.71	-7.47	-7.63	-1.33	-0	-0
Income Tax	-11.6	0.07	-0.11	0.03	0.02	0.04	0	0	0	-0
Net Income	1.55	-22.65	-17.18	-8.31	-4.71	-7.47	-7.63	-1.33	-0	-0
Shares Outstanding (Basic)	65	54	50	32	26	24	17	16	0	0
Shares Outstanding (Diluted)	65	54	50	32	26	24	17	16	0	0
Shares Change	19.25%	9.31%	55.68%	24.25%	5.36%	44.08%	5.73%	102438.71%	-	-
EPS (Basic)	0.02	-0.42	-0.35	-0.26	-0.18	-0.31	-0.45	-0.08	-0.05	-0.05
EPS (Diluted)	0.02	-0.42	-0.35	-0.26	-0.18	-0.31	-0.45	-0.08	-0.05	-0.05
Free Cash Flow	-12.66	-23.58	-15.31	-8.95	-8.04	-10.12	-7.31	-2.57	-0	-0
Free Cash Flow Per Share	-0.20	-0.43	-0.31	-0.28	-0.31	-0.42	-0.43	-0.16	-0.06	-0.04
EBITDA	-21.64	-22.26	-17.15	-8.2	-4.74	-7.37	-7.66	-1.2	-0	-0
Depreciation & Amortization	0	0.04	0.04	0.01	0.01	0.01	0.01	0	0	0
EBIT	-21.64	-22.3	-17.19	-8.21	-4.75	-7.38	-7.67	-1.2	-0	-

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.